| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.4B | $5.0B | $5.5B | $5.4B | $4.9B | $4.2B | $4.3B | — |
| Cost of Revenue | $2.0B | $1.8B | $1.9B | $2.0B | $1.9B | $1.7B | $1.8B | $1.8B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $1.0B | $0.9B | $0.9B | $0.8B | $0.8B | $0.7B | $0.7B | $0.6B |
| SG&A Expense | $1.5B | $1.4B | $1.3B | $1.3B | $1.2B | $1.1B | $1.2B | $1.2B |
| Operating Income | $0.9B | $0.8B | $1.4B | $1.3B | $1.1B | $0.8B | $0.7B | $-0.3B |
| Net Income | $0.8B | $0.6B | $1.1B | $1.1B | $0.9B | $0.6B | $0.6B | $0.2B |
| EPS (Basic) | $4.93 | $3.53 | $5.95 | $6.23 | $4.84 | $3.35 | $3.31 | $0.88 |
| EPS (Diluted) | $4.91 | $3.51 | $5.91 | $6.18 | $4.78 | $3.31 | $3.25 | $0.86 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.3B | $9.3B | $8.7B | $8.1B | $7.8B | $7.2B | $6.6B | $5.8B |
| Current Assets | $4.3B | $4.3B | $4.8B | $4.2B | $3.8B | $3.4B | $3.2B | $2.4B |
| Cash & Equivalents | $1.9B | $1.8B | $2.5B | $2.0B | $2.1B | $1.8B | $1.6B | $0.9B |
| Total Liabilities | $5.4B | $4.2B | $4.0B | $3.9B | $4.0B | $3.9B | $3.6B | $3.4B |
| Current Liabilities | $1.9B | $1.4B | $2.0B | $1.4B | $1.3B | $1.1B | $1.0B | $1.5B |
| Stockholders' Equity | $5.9B | $5.1B | $4.7B | $4.2B | $3.8B | $3.3B | $3.0B | $2.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.1B | $1.4B | $1.1B | $1.3B | $1.0B | $1.0B | $0.6B |
| Investing Cash Flow | $-1.7B | $-0.8B | $-0.3B | $-0.3B | $-0.4B | $-0.4B | $-0.2B | $-0.1B |
| Capital Expenditures | $0.1B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $0.4B | $-0.9B | $-0.7B | $-0.9B | $-0.7B | $-0.4B | $-0.1B | $-0.3B |